David Sinclair, a leading geneticist at Harvard University, has revealed a significant breakthrough in the treatment of aging, saying that aging is not an inevitable process but a treatable medical condition. According to a foreign news agency, Dr. Sinclair said at an event that his research team has succeeded in reducing the signs of aging in animals by 75% through partial epigenetic programming. He said that modified Yamanaka genes were used in this process, with the help of which the vision of some blind animals was also restored. Dr. Sinclair said that these technologies can restore cells to a youthful state, which improves physical function and strength. Scientists have discovered ways to restore cell function, which can reduce the effects of aging. He said that human clinical trials are now being prepared to test epigenetic programming therapies. For the first time in history, it will be seen whether it is possible to reverse aging and treat age-related diseases. Dr. Sinclair also highlighted the potential economic benefits of this research, saying that if healthy life expectancy were to increase by just one year, it could benefit the economy by trillions of dollars. Experts say that the final results will be revealed only after human trials, and more scientific evidence is awaited in this regard.















